Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126160033 | 12616003 | 3 | F | 201607 | 20160826 | 20160802 | 20160901 | EXP | JP-PFIZER INC-2016367273 | PFIZER | 66.00 | YR | M | Y | 169.00000 | KG | 20160901 | CN | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126160033 | 12616003 | 1 | PS | TOVIAZ | FESOTERODINE FUMARATE | 1 | Oral | 4 MG, DAILY | Y | 22030 | 4 | MG | PROLONGED-RELEASE TABLET | ||||||
| 126160033 | 12616003 | 2 | SS | TOVIAZ | FESOTERODINE FUMARATE | 1 | 8 MG, 1X/DAY (AT NIGHT) | Y | 22030 | 8 | MG | PROLONGED-RELEASE TABLET | QD | ||||||
| 126160033 | 12616003 | 3 | C | LOSARHYD | HYDROCHLOROTHIAZIDELOSARTAN POTASSIUM | 1 | 0 | ||||||||||||
| 126160033 | 12616003 | 4 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | 0 | ||||||||||||
| 126160033 | 12616003 | 5 | C | ATORVASTATIN | ATORVASTATIN | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126160033 | 12616003 | 1 | Hypertonic bladder |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126160033 | 12616003 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126160033 | 12616003 | Condition aggravated | |
| 126160033 | 12616003 | Drug ineffective | |
| 126160033 | 12616003 | Dry mouth | |
| 126160033 | 12616003 | Dysphagia | |
| 126160033 | 12616003 | Dysphonia | |
| 126160033 | 12616003 | Hypotonic urinary bladder | |
| 126160033 | 12616003 | Lip dry | |
| 126160033 | 12616003 | Thirst | |
| 126160033 | 12616003 | Urinary retention |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126160033 | 12616003 | 1 | 20160726 | 20160726 | 0 | |
| 126160033 | 12616003 | 2 | 20160727 | 201607 | 0 |